Development and Characterization of Intravenous Nanoemulsions Loaded with Magnolia officinalis Neolignans
Molecules · 2026
DOI: 10.3390/molecules31111939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Katarzyna Dominiak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-802 Poznan, Poland. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds, Magnolia, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.
Abstract (Originalsprache)
Honokiol (HON) and magnolol (MAG), hepatoprotective neolignans from Magnolia spp., are promising candidates for mitigating liver damage associated with long-term parenteral nutrition (PN). However, their clinical use is limited by poor aqueous solubility. This study aimed to develop a multifunctional nanoemulsion platform based on clinically used lipid nanoemulsions (Lipofundin®/Lipidem®), enriched with omega-3 fatty acids and loaded with HON, MAG, or a combination of both. Nanoemulsions were prepared using a two-step homogenization process. Pre-emulsions containing HON, MAG, or both neolignans were first obtained using high-shear homogenization, then mixed in a 1:1 volume ratio with Lipofundin or Lipidem and subsequently subjected to high-pressure homogenization. All nanoemulsions met pharmacopeial standards and literature-recommended quality criteria. The formulations showed mean droplet diameters below 500 nm, PFAT5 values below the 0.05% limit, and PDI values < 0.2. Strongly negative zeta potentials (≤−30 mV) confirmed stability. The formulations were non-hemolytic, fully compatible with PN admixtures for 24 h, and non-cytotoxic in THLE-2 cells. Furthermore, all developed nanoemulsions demonstrated lower in vitro hepatotoxicity than clinically used reference formulations, indicating their promising clinical potential. However, further in vivo studies are required to confirm their therapeutic benefits and hepatoprotective effect during parenteral nutrition (PN).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-802 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, 70 Bukowska, 60-812 Poznan, Poland.
- Department of Toxicology, Poznan University of Medical Sciences, 3 Rokietnicka, 60-806 Poznan, Poland.
- Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, 3 Rokietnicka, 60-806 Poznan, Poland.
- Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-806 Poznan, Poland.
ORCID-Profile: Aleksandra Gostyńska-Stawna, Magdalena Ratajczak, Violetta Krajka-Kuźniak, Maciej Stawny
Förderung
- National Science Centre
Zitieren
APA
Dominiak, K., Gostyńska-Stawna, A., Sommerfeld-Klatta, K., Ratajczak, M., Krajka-Kuźniak, V., & Stawny, M. (2026). Development and Characterization of Intravenous Nanoemulsions Loaded with Magnolia officinalis Neolignans. Molecules. https://doi.org/10.3390/molecules31111939
Vancouver
Dominiak K, Gostyńska-Stawna A, Sommerfeld-Klatta K, Ratajczak M, Krajka-Kuźniak V, Stawny M. Development and Characterization of Intravenous Nanoemulsions Loaded with Magnolia officinalis Neolignans. Molecules. 2026. doi:10.3390/molecules31111939
BibTeX
@article{Dominiak2026,
author = {Dominiak, Katarzyna and Gostyńska-Stawna, Aleksandra and Sommerfeld-Klatta, Karina and Ratajczak, Magdalena and Krajka-Kuźniak, Violetta and Stawny, Maciej},
title = {Development and Characterization of Intravenous Nanoemulsions Loaded with Magnolia officinalis Neolignans},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31111939}
}
EUVIMED